Catalytic therapy of cancer with porphyrins and ascorbate

Cancer Letters

Volumn 252, Issue 2, 2007, Pages 216-224

  Heck, Diane E ^b  

^a Torshina), Nadejda   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; Ascorbate; Cancer; Catalytic; Cell cycle; DNA; Porphyrins; Sub G0 G1; Therapy

Indexed keywords

ASCORBIC ACID; METAL ION; PHTHALOCYANINE; PORPHYRIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CATALYST; CATALYTIC THERAPY; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR CELL;

ANIMALS; ASCORBIC ACID; BREAST NEOPLASMS; CATALYSIS; CELL LINE, TUMOR; HUMANS; MELANOMA, EXPERIMENTAL; MICE; PORPHYRINS; REACTIVE OXYGEN SPECIES;

EID: 34249708326     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.12.026     Document Type: Article

References (59)

1. Triesscheijn M., Baas P., Schellens J.H., and Stewart F.A. Photodynamic therapy in oncology. Oncologist 9 (2006) 1034-1044
2. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-508
3. Juzeniene A., Nielsen K.P., and Moan J. Biophysical aspects of photodynamic therapy. J. Environ. Pathol. Toxicol. Oncol. 25 (2006) 7-28
4. Feofanov A.V., Grichine A.I., Shitova L.A., et al. Confocal Raman microspectroscopy and imaging study of theraphthal in living cancer cells. Biophys. J. 78 (2000) 499-512
5. Plaetzer K., Kiesslich T., Oberdanner C.B., and Krammer B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr. Pharm. Des. 11 (2005) 1151-1165
6. Fuchs J., Weber S., and Kaufmann R. Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Radic. Biol. Med. 28 (2000) 537-548
7. Heck D.E., Vetrano A.M., Mariano T.M., and Laskin J.D. UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J. Biol. Chem. 278 (2003) 22432-22436
8. Heck D.E., Gerecke D.R., Vetrano A.M., and Laskin J.D. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol. Appl. Pharmacol. 195 (2004) 288-297
9. Kelley E.E., Domann F.E., Buettner G.R., et al. Increased efficacy of in vitro Photofrin photosensitization of human oral squamous cell carcinoma by iron and ascorbate. J. Photochem. Photobiol. B 40 (1997) 273-277
10. Vol'pin M.E., Krainova N.Yu., Levitin I.Ya., et al. B12 compounds in combination with ascorbic acid as potential antitumor agents. Mendeleev Chem. J. 42 (1998) 116-127
11. Dikalov S.I., Vitek M.P., Mason R.P., et al. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radic. Biol. Med. 36 (2004) 340-347
12. Akatov V.S., Evtodienko Y.V., Leshchenko V.V., et al. Combined vitamins Bl2 and C induce the glutathione depletion and the death of epidermoid human larynx carcinoma cells HEp-2. Biosci. Rep. 20 (2000) 411-418
13. Kogan B.Y., Butenin A.V., Torshina N.L., et al. Aluminium sulphophthalocyanine as an NIR photosensitizer for PDT. Proc. SPIE 3563 (1999) 148-151
14. Buettner G.R. Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light. Cancer Lett. 25 (1985) 297-304
15. Afonso S.G., de Salamanca A.E., Batlle A.M., et al. The photodynamic and non-photodynamic actions of porphyrins. Braz. J. Med. Biol. Res. 32 (1999) 255-266
16. Khanum J.V. Effects of hematoporphyrin derivative on the cellular energy metabolism in the absence and presence of light. Photochem. Photobiol. 50 (1989) 647-651
17. Proteggente A.R., England T.G., Rice-Evans C.A., et al. Iron supplementation and oxidative damage to DNA in healthy individuals with high plasma ascorbate. Biochem. Biophys. Res. Commun. 19 (2001) 245-251
18. Proteggente A.R., Rehman A., Halliwell B., et al. Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo. Biochem. Biophys. Res. Commun. 277 (2000) 535-540
19. Poydock M.E., Tardon J.C., Gallina D., et al. Inhibiting effect of vitamins C and B12 on the mitotic activity of ascites tumors. Exp. Cell Biol. 47 (1979) 210-217
20. Poydock M.E. Effect of combined ascorbic acid and B12 on survival of mice with implanted Ehrlich carcinoma and L1210 leukemia. Am. J. Clin. Nutr. 54 (1991) 1261S-1265S
21. Poydock M.E., Harguindey S., Hart T., et al. Mitogenic inhibition and effect on survival of mice bearing L1210 leukemia using a combination of dehydroascorbic acid and hydroxycobalamin. Am. J. Clin. Oncol. 8 (1985) 266-275
22. Poydock M.E., Reikert D., Rice J., et al. Influence of vitamins C and B12 on the survival rate of mice bearing ascites tumor. Exp. Cell Biol. 50 (1982) 88-91
23. Pierson H.F., Fisher J.M., Rabinovitz M., et al. Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy. Cancer Res. 45 (1985) 4727-4731
24. Kalija O.L., Meerovich G.A., Torshina N.L., et al. Improvement of cancer PDT using sulphophthalocyanine and sodium ascorbate. Proc. SPIE 3191 (1997) 177-179
25. Gal'perin E.L., Diuzheva T.G., Nakhamiiaev V.R., et al. Selective-occlusive method of drug administration in the treatment of experimental liver tumors. Khirurgiia 8 (2001) 24-32
26. Madzhuga A.V., Ermakova N.P., Chlenova E.L., et al. Effects of theraphthal-Lio on hemostasis in experimental animals. Vopr. Onkol. 47 (2001) 715-722
27. Mikhailova L.M., Ermakova N.P., Chlenova E.L., et al. Toxicity of binary "theraphthal-Lio + ascorbic acid" (TPH + AA) catalytic system during different methods of regional intra-arterial administration in dogs. Vopr. Onkol. 47 (2001) 710-714
28. Mikhailova L.M., Ermakova N.P., Chlenova E.L., et al. Preclinical toxicological study of theraphthal-Lio and binary catalytic system "theraphthal-Lio + ascorbic acid". Vopr. Onkol. 47 (2001) 695-700
29. Garin A.M., Gorbunova V.A., Gershanovich M.L., et al. Results of a phase I clinical trial of "theraphthal + ascorbic acid" catalytic system. Vopr. Onkol. 47 (2001) 676-685
30. Halliwell B., and Foyer C.H. Ascorbic acid, metal ions and the superoxide radical. Biochem. J. 155 (1976) 697-700
31. Cameron E., Pauling L., and Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res. 39 (1979) 663-681
32. Chen .Q., Espey M.G., Krishna M.C., Mitchell J.B., et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl. Acad. Sci. USA 102 (2005) 13604-13609
33. Keller K.M., and Pollard E.C. Action of hydrogen peroxide on degradation of DNA after irradiation in E. coli. Int. J. Radiat. Biol. 31 (1977) 407-413
34. Massie Y., Kitahara M., Maeda K., and Umezawa H. The kinetics of degradation of DNA and RNA by hydrogen peroxide. Biochem. Biophys. Acta 272 (1972) 539-548
35. Meneghini R., and Hoffmann M.E. The damaging action of hydrogen peroxide on DNA of human fibroblasts is mediated by a non-dialyzable compound. Biochim. Biophys. Acta 608 (1980) 167-173
36. Beuttner G.R., Doherty T.P., and Bannister T.D. Hydrogen peroxide and hydroxyl radical formation by methylene blue in the presence of ascorbic acid. Radiat. Environ. Biophys. 23 (1984) 235-243
37. Koizumi M., and Usui Y. Fundamental aspects of the oxidative and reductive photobleaching of xanthene and thiazine dyes. Mol. Photochem. 4 (1972) 57-92
38. Buettner G.R., and Need M.J. Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate, and light. Cancer Lett. 25 (1985) 297-304
39. Magda D., Lepp C., Gerasimchuk N., et al. Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 1025-1036
40. Sessler J.L., and Miller R.A. Texaphyrins: New drugs with diverse clinical application in radiation and photodynamic therapy. Biochem. Pharmacol. 59 (2000) 733-739
41. Sharman W.S., Allen C.M., and van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov. Today 4 11 (1999) 507-517
42. Vol'pin M.E., Belkov N.F., Krynetskaya Z.A., Shabarova G., et al. Transition-metal complexes as catalysts of active oxygen species formation in autooxidation reactions. Cobalt and iron phthalocyanine complexes. Russ. Chem. Bull. 45 (1996) 2105-2111
43. Girenko E.G., Borisenkova S.A., and Kalija O.L. Oxygenation of ascorbic acid in the presence of metal phthalocyanines (Chemical aspects of catalytic therapy of cancer. Topic 1. Catalysis of oxygenation by phthalocyanine Co, Academy of science news). Chem. Ser, 07 (2002) 1137-1142
44. B.A.Kyrlandsky, E.V.Braude, N.L.Torshina, The study of metabolism of phthalocyanine dyes by HPLC. 3 Russian symposium HPLC, Riga, (1984), pp.183.
45. Kyrlandsky B.A., Braude E.V., Klachkina A.M., Torshina N.L., et al. Cu phthalocyanine toxicity study. Hygiene and sanitary 5 (1985) 92-93
46. Torshina N.L., Braude E.V., and Kyrlandsky B.A. Serum and urine influence on phthalocyanine dyes aggregation. Hygiene and Sanitaria 10 (1987) 87
47. Balabanova E.L., Kyrlandsky B.A., Torshina N.L., et al. The phthalocyanine toxicity bond with their allocation on serum protein. Hygiene of work and professional illness 10 (1989) 54-56
48. Kyrlandsky B.A., Torshina N.L., Balabanova E.L., et al. Soluble phthalocyanine dyes toxic action hangs. Hygiene of work and professional illness 10 (1988) 47-48
49. Kyrlandsky B.A., Torshina N.L., Braude E.V., and body S.p.d.i.t.b.i.t. Hygiene of work and professional illness 4 (1987) 49-57
50. Bohmer R.M., Hoffmann K., and Morstyn G. Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity. Cancer Chemother. Pharmacol. 20 (1987) 16-20
51. Canti G., Franco P., Marelli O., et al. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210). Cancer Res. 44 (1984) 1551-1556
52. Chieli E., and Malvaldi G. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 31 (1984) 41-52
53. Howe L., and Zhang J.Z. The effect of biological substrates on the ultrafast excited-state dynamics of zinc phthalocyanine tetrasulfonate in solution. Photochem. Photobiol. 67 (1998) 90-96
54. Howe L., and Zhang J.Z. Ultrafast studies of excited-state dynamics of phthalocyanine and zinc phthalocyanine tetrasulfonate in solution. Phys. Chem. A 101 (1997) 3207-3213
55. Torshina N.L., Posypanova A.M., and Volkova A.I. Photodynamic effect occurrence in photosensitizer mixtures with albumin or blood serum, or hemoglobin and blood. Proc. SPIE 2923 (1996) 35-43
56. N.L. Torshina, S.S. Kharnas, A.M. Possypanova et al, Clinical results of updating method of a photodynamic therapy with "Photosens": use as transport protein human albumins and fractional injection, in: First Internet Conference Photochemistry and Photobiology, vol. 11, 1997.
57. Damia G., and Broggini M. Improving the selectivity of cancer treatments by interfering with cell response pathways. Eur. J. Cancer 40 (2004) 2550-2559
58. Kuznetsov A.A., Filippov V.I., Alyautdin R.N., Torshina N.L., et al. Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs. J. Magn. Magnetic Mater. 225 (2001) 95-100
59. Cinteza l.T., Ohulchanskyy Y., Sahoo E.J., et al. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol. Pharm. 3 4 (2006) 415-423